ID

24794

Beskrivning

Study ID: 101468/228 Clinical Study ID: 101468/228 Study Title:A two year Phase IIIb randomised, multicenter, double-blind, SINEMET controlled, parallel group, flexible dose study, to assess the effectiveness of controlled release ropinirole add-on therapy to L-dopa at increasing the time to onset of dyskinesia in Parkinson's disease subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00363727 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Dyskinesias; Parkinson Disease; Parkinson's Disease Study part: Concomitant Medications.

Nyckelord

Versioner (4)
  1. 2017-08-11 2017-08-11 -
  2. 2017-08-18 2017-08-18 -
  3. 2017-08-18 2017-08-18 -
  4. 2017-09-08 2017-09-08 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

18 augusti 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Concomitant Medications GSK study Dyskinesia in Parkinson's disease NCT00363727

Engelsk

Concomitant Medications study Dyskinesia in Parkinson's disease NCT00363727

1 Formulär  
General information
Beskrivning

General information

Protocol indentifier
Beskrivning

Protocol indentifier

Datatyp

text

Subject Identifier
Beskrivning

Subject Identifier

Datatyp

text

Alias
UMLS CUI [1]
C2348585
Visit date
Beskrivning

Visit date

Datatyp

date

Visit Description
Beskrivning

Visit Description

Datatyp

text

Concomitant medication
Beskrivning

Concomitant medication

Concomitant medication
Beskrivning

Record any changes to the subject's concomitant medications or any new medications taken since the last visit in the appropriate Concomitant Medications section.

Datatyp

text

L-Dopa medication changes
Beskrivning

L-Dopa medication changes

Has there been any change in dose or frequency of L-Dopa medication since the last visit?
Beskrivning

Note: Record any changes to the subject's L-Oopa medication taken since the last visit in the L-Dopa Medication section and contact GSK

Datatyp

boolean

Parkinson's Disease Symptom Control
Beskrivning

Parkinson's Disease Symptom Control

Does the subject experience a reduction in Parkinson's Disease symptom control within 4 hours of the dose of L-dopa?
Beskrivning

Parkinson's Disease Symptom Control

Datatyp

boolean

Tillbaka till toppen

Similar models

Concomitant Medications study Dyskinesia in Parkinson's disease NCT00363727

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
General information
Protocol indentifier
Item
Protocol indentifier
text
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit date
Item
Visit date
date
Visit Description
Item
Visit Description
text
Item Group
Concomitant medication
Concomitant medication
Item
Concomitant medication
text
Item Group
L-Dopa medication changes
change of L-Dopa medication
Item
Has there been any change in dose or frequency of L-Dopa medication since the last visit?
boolean
Item Group
Parkinson's Disease Symptom Control
Parkinson's Disease Symptom Control
Item
Does the subject experience a reduction in Parkinson's Disease symptom control within 4 hours of the dose of L-dopa?
boolean
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial